Fundraising Fox
Robert Adelman
InvestorBoard director at Metacrine · Board director at Solstice Biologics · Board director at Precision BioSciences · Former Co-founder and Emeritus Managing Partner at venBio Partners
Find your path to Robert
23 people in our graph can introduce you to Robert.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Lou Tartaglia to introduce you to Robert
You →Lou · together at Solstice Biologics →Robert
Ask Jamie Chen to introduce you to Robert
You →Jamie · together at Solstice Biologics →Robert
Ask Sam Okafor to introduce you to Robert
You →Sam · 4 people · together at Precision BioSciences →Robert
Sign up to find every way you can get introduced to Robert
- Your email: the people you already email who know Robert
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Robert
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Robert Adelman, a surgeon-turned-investor, brings clinical experience to therapeutics boardrooms and has backed oncology and immunology platforms later acquired by major pharma like Aragon (J&J) and Turning Point (BMS).
Invests in
BiotechHealthtech
Board director at Metacrine
Intro paths
In turn, Robert can intro founders to Metacrine's investors below.
Metacrine's investors · 15
Co-founders at Metacrine
Board director at Solstice Biologics
Intro paths
In turn, Robert can intro founders to Solstice Biologics's investors below.
Solstice Biologics's investors · 1
Board director at Precision BioSciences
Intro paths
In turn, Robert can intro founders to Precision BioSciences's investors below.
Precision BioSciences's investors · 13
Co-founders at Precision BioSciences
Deals · 4
TP TherapeuticsBoard seat
via venBio Partners · filed Oct 2018 · $80M raise
Precision BioSciencesBoard seat
via venBio Partners · filed Jun 2018 · $110M raise
MetacrineBoard seat
via venBio Partners · filed Nov 2016 · $37.8M raise
Solstice BiologicsBoard seat
via venBio Partners · filed Dec 2015 · $4M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Led
Alexo TherapeuticsApellis PharmaceuticalsAragon PharmaceuticalsSeragon PharmaceuticalsTurning Point Therapeutics
Board seats
Sources: the firm's website · SEC Form D filings.
Frequently asked questions
- Who is Robert Adelman?
- Robert Adelman, a surgeon-turned-investor, brings clinical experience to therapeutics boardrooms and has backed oncology and immunology platforms later acquired by major pharma like Aragon (J&J) and Turning Point (BMS).
- Where does Robert Adelman work?
- Robert Adelman is Board director at Metacrine and Board director at Solstice Biologics and Board director at Precision BioSciences.
- What does Robert Adelman invest in?
- Robert Adelman invests in Biotech, Healthtech.
- What boards does Robert Adelman sit on?
- Robert Adelman holds tracked board seats at Apellis Pharmaceuticals, Metacrine, Precision BioSciences, Solstice Biologics, TP Therapeutics.
- What companies has Robert Adelman invested in?
- Investments tracked here include Alexo Therapeutics, Apellis Pharmaceuticals, Aragon Pharmaceuticals, Seragon Pharmaceuticals, Turning Point Therapeutics.
- Does Robert Adelman lead rounds?
- Yes — Robert Adelman has led 5 tracked investments.